Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Intravascular Imaging: A Universal Approach for Angioplasty Optimization

Despite robust information supporting the use of intravascular imaging during coronary angioplasty, its use in clinical practice remains low. This paper proposes using an algorithm for decision-making throughout the procedure to promote increased intravascular imaging use.

El uso del ultrasonido intravascular en la angioplastia de tronco no protegido se asocia con mejores resultados en comparación con la angioplastia guiada solo por angiografía.

Regardless of the many technologies that have been incorporated into strut design struts and polymer type, the rate of stent failure has not changed significantly in recent years.

Outcome improvement seems not to depend on a new and better stent, but on a refined implantation technique. Here is where intravascular imaging—which should already be standard of care—becomes essential.

In spite of their significant differences, intravascular ultrasound (IVUS) and optical coherence tomography (OCT) can be used interchangeably in most clinical scenarios. Both technologies allow co-registration with angiography and functional measurements.


Read also: Risk of Coronary Obstruction in Repeat TAVR.


However, there are some specific cases where one technology is clearly more beneficial than the other.

  • Left main coronary artery disease: IVUS is better than OCT in evidence and practicality, allowing the evaluation of both the bifurcation and the ostium.
  • Ostial lesion: IVUS is the clear choice. The need to inject contrast to have clear images with OCT is hampered by not being able to intubate the guidewire.
  • In-stent restenosis: Both technologies are useful, but OCT comes on top because of its much sharper images to define malapposition or lack of strut coverage.
  • Calcium: Both tools are suitable; however, OCT is preferred—again—because of its high resolution.
  • Chronic total occlusion: IVUS is more useful to direct the guidewire to the true lumen.
  • Stent sizing and optimization: Both technologies are valuable. The minimal in-stent lumen area is the greatest predictor of events, and it can be measured and optimized with both tools.
  • Plaque rupture and thrombosis: In acute coronary syndromes, OCT is a clear winner in finding the culprit lesion. OCT advantages include the possibility of observing plaque rupture, measuring cap thickness, detecting inflammation, and more.
  • Chronic kidney disease: The need to inject contrast and the limitation in the length of the pullbacks make OCT unsuitable for patients with renal impairment.

Regardless of their differences (and their availability), using at least one of them is paramount. Currently, intravascular imaging is the best hope for improving angioplasty results.

Original title: Intravascular Imaging-Guided Percutaneous Coronary Intervention. A Universal Approach for Optimization of Stent Implantation.

Reference: Evan Shlofmitz, DO et al. Circ Cardiovasc Interv. 2020;13:e008686. DOI: 10.1161/CIRCINTERVENTIONS.120.008686.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...